Author: buddigest

Hudson, New York is about to get loud — in the best possible way.

Having attended Revelry’s New York Buyers Club, I can sum up the experience in one word: energy. The room crackled with it. Revelry is the rare gathering where you feel like you’re at a party and a board meeting at the same time, in the best sense of both. Deals are being sketched out over handshakes, introductions are snowballing into real opportunities, and you can practically see the New York market knitting itself together in real time.

One moment from the New York event has really stuck with me. I spoke with a California participant — the kind of industry veteran who remembers the “glory days” of California cannabis before harsh market realities sank in. They told me Revelry New York was the best conference they’d been to since those early golden years. That’s not a small compliment from someone who’s seen every flavor of cannabis show over the last decade.

What sets Revelry apart is how condensed — and therefore dense — it is. There’s no wandering through endless aisles of booths hoping to bump into the right person. Instead, decisionmakers are intentionally intermingling. Brand

Read More Here...

MJ Unpacked is rolling back into Atlantic City on May 5–7, and it feels less like another cannabis conference and more like a family reunion at the shore—with much better weed. This is more than just a date on the industry calendar; it’s the rare event where operators, brands, investors, and policy nerds all actually show up, lean in, and get real about where this market is headed.

The pier party you never got as a kid

I still haven’t stopped thinking about the last time MJ Unpacked took over the pier for the afterparty. That night is firmly cemented as one of the most memorable events I’ve ever been to. Walking onto the pier with the rides lit up, the ocean wind in your face, and top-shelf product in your pocket felt like taking a trip back into your childhood—only this time you’re armed with amazing weed products and your childlike wonder and awe at the sheer awesomeness of it all. It was pure joy layered on top of real industry connection, which is a combination you just don’t get often in this business.

That’s the energy MJ Unpacked is bringing back to Atlantic City in 2026. The after-hours experience isn’t

Read More Here...

President Donald Trump (R) last week signed an executive order to support psychedelics as a potential treatment for some mental health conditions. The order directs $50 million in federal funds to make the drugs more accessible via state-run programs, and requires the Food and Drug Administration (FDA) to expedite a review of some psychedelic drugs, including psilocybin and ibogaine. 

The order includes a provision that would require “timely rescheduling” of any current Schedule 1 substance that successfully completes Phase 3 clinical trials for a serious mental health disorder.   

“Individuals suffering from major depressive disorder and substance abuse disorder, among other serious mental illnesses, can relapse or not fully respond to standard medical and psychiatric therapies.  Despite massive Federal investment into researching potential advancements in mental health care and treatment, our medical research system has yet to produce approved therapies that promote enduring improvements in the mental health condition of these most complex patients.  Innovative methods are needed to find long-term solutions for these Americans beyond existing prescription medications.” — “Accelerating Medical Treatments for Serious Mental Illness” Executive Order, 4/18/26  

In a video of Trump signing the order, podcaster Joe Rogan, who attended the ceremony, noted that “These drugs are illegal not because they are harmful” but “because of the 1970 Controlled Substances Act.” 

“For 56 years we’ve lived under those terrible

Read More Here...

BOCA RATON, FL — Springbig (OTCQX: SBIG), the AI-powered marketing and customer engagement platform serving regulated retailers and brands, today announced the launch of AI Audience Builder, a breakthrough capability that enables retailers to create precisely targeted customer segments using plain, natural language powered by artificial intelligence. No filters. No manual logic. No data expertise required.

The launch positions Springbig at the forefront of AI-driven retail marketing, delivering a tangible productivity and revenue advantage to dispensary operators competing in an increasingly data-intensive market.

Instead of navigating complex segmentation workflows, marketers can now describe an audience in their own words and watch Springbig’s AI instantly build it, dramatically compressing the time from insight to campaign execution.

Transforming How Marketers Work With Data

Audience segmentation has long been one of the most powerful, yet consistently underutilized, levers in retail marketing. The barrier has never been data availability. It has been accessibility.

Traditional segmentation requires marketing teams to build logic manually, configure multiple filters, and maintain a working knowledge of underlying data structures. For operators running lean teams across multiple locations, that friction translates directly into missed revenue opportunities.

AI Audience Builder removes that barrier entirely. Key capabilities include:

Natural language audience

Read More Here...

The North Carolina Department of Health and Human Services’ Advisory Council on Cannabis called for legalizing adult-use cannabis in an interim report issued last week, and Gov. Josh Stein (D) has endorsed the advisory group’s proposal.

North Carolina is one of the last remaining states in the U.S. without any form of cannabis legalization.

Notably, while most states have followed a trend of legalizing medical cannabis before adopting adult-use reforms, the advisory group has suggested jumping straight to full legalization, as standing up and regulating a single industry is much easier than two, and that a medical-only program “could fuel an already robust illicit market, without regulation to ensure consumer safety.”

The advisory committee was appointed last year by the governor, who compared the state’s illicit cannabis market to the “Wild West” and endorsed the committee’s plan over the weekend, calling for a “safe, legal, and well-regulated market for adults.”

“Last year, I charged this group with developing a comprehensive solution to the unregulated sale of cannabis that is grounded in public health and public safety, with a special focus on keeping young people safe. This report provides the General Assembly with guidance and makes clear that a well-regulated market,

Read More Here...

Washington, D.C. Mayor Muriel Bowser (D) last week introduced a bill that would allow local breweries to partner with licensed medical cannabis manufacturers to produce cannabis-infused beverages. 

“This is an opportunity to support two local industries and to keep business in DC. We have fantastic local brewers and distillers in our city, we have a robust medical cannabis market, and this is a new opportunity for those two markets to collaborate and create a safe and smoke-free alternative for patients in DC.” — Bowser in a press release 

The proposal would also allow a license endorsement for breweries and distilleries to manufacture cannabis-infused products and an endorsement for medical cannabis manufacturers to import non-intoxicating cannabinoids for use in production. 

Under the plan, all products would be subject to mandatory testing and would be alcohol-free. The products would only be sold at licensed dispensaries and would be available only to registered medical cannabis patients.  

In a statement, Fred Moosally, director of the Alcoholic Beverage and Cannabis Administration, said the proposal “makes sense.”  

“Providing a legal pathway for our local breweries and distilleries to utilize their expertise in beverage production is the logical next step in maturing DC’s medical cannabis marketplace and supporting our local business ecosystem,” he said.  

According to the legislation fact sheet, the beverages would be subject to a 6% sales tax,

Read More Here...

Nebraska lawmakers last week approved a bill to allow the state Medical Cannabis Commission to set fees and raise revenue, the Nebraska Examiner reports. The legislation is the first-ever bill related to the voter-approved medical cannabis to be approved by state lawmakers. 

Crista Eggers, executive director of Nebraskans for Medical Marijuana, told the Examiner that the bill’s passage is “one very small step” but “something to celebrate.” 

“Still so much that has to be done to turn this into a program patients can actually access. And until we see that day, we cannot call it success.” — Eggers to the Examiner 

Lawmakers are currently considering another bill that is important for the state’s medical cannabis program to function. LB 933 would pay medical cannabis commissioners $12,500 for their work; create a fund to collect fees gifts, grants, and other monies collected by the commission; authorize the commission to set medical cannabis industry application fees, with a $50,000 cap; and require medical cannabis license applicants to submit to background checks. 

LB 933 passed the first round of debate 30-7 on March 20 and needs to pass two more rounds by April 17. The bill requires at least 33 votes to become law. 

Read More Here...

Multi-state cannabis firm The Cannabist Company announced last week that it is selling off all of its ownership interests in its subsidiaries and seeking to enter Chapter 15 bankruptcy. 

The Massachusetts-based company said it had already sold its stake in Virginia’s Green Leaf Medical to Parma for $130 million in a deal that closed in February. 

On March 23, the company said it had entered into an agreement with Holistic for the sale of its Ohio holdings, which includes: Columbia Care LLC; Columbia Care OH, LLC; Corsa Verde, LLC; Cannascend Alternative, LLC; Cannascend Alternative Logan, LLC; Green Leaf Medical of Ohio II, LLC; CC OH Realty, LLC; and Green Leaf Medical of Ohio III, LLC. The deal is worth $47 million, including $34.5 million in cash and a $12.5 million promissory note from Holistic, and is expected to close during the third quarter of the year. 

In a separate March 23 agreement, Cannabist agreed to sell its Columbia Care Delaware, LLC subsidiary to Parma for $16.5 million in cash. That deal is expected to close during the second quarter of this year. 

The company said it is still finalizing deals for its assets and subsidiaries in Colorado, Illinois, Maryland, Massachusetts, New Jersey, and West Virginia. In connection with the bankruptcy, Cannabist has ceased all of its New York operations and is in the process of shutting down its Pennsylvania operations. 

Cannabist indicated it has appointed SierraConstellation Partners LLC as chief restructuring

Read More Here...

In this episode of The Ganjapreneur Podcast, host TG Branfalt speaks with Dr. Gil Fanciullo, a longtime physician specializing in pain management and palliative care, about his early experiences recommending cannabis to patients well before it was legally accepted. Drawing from decades in medicine, including his work at Dartmouth-Hitchcock Medical Center, Fanciullo reflects on the risks physicians once faced, the patient-driven origins of medical cannabis adoption, and how attitudes within the medical community have evolved over time.

This interview explores the gaps that still exist in cannabis research, the complexities of cannabinoids and the so-called “entourage effect,” and the role cannabis could play in reducing reliance on pharmaceuticals like opioids. Fanciullo also discusses physician education, regulatory barriers, and what federal rescheduling could mean for both medical practice and the broader cannabis industry. Listen to the full episode below, or wherever you get your podcasts!

Listen to the episode: Read the transcript:

TG Branfalt (00:06):

Hey there. I’m your host, TG Branfalt, and this is the Ganjapreneur.com podcast where we try to bring you actionable information and normalize cannabis through the stories of entrepreneurs, activists, and industry stakeholders. Today, I am joined by Dr. Gil Fanciullo. He’s Professor Emeritus Dartmouth Medical

Read More Here...

The Missouri General Assembly last week sent a bill to Gov. Mike Kehoe’s (R) desk that seeks to ban the sale of intoxicating hemp products starting November 12, First Alert 4 reports.

The proposal, House Bill 2641, seeks to align state law with an incoming shift in federal policy pushed by Republican lawmakers and signed into law by President Trump last year. Those changes, implemented as part of a spending bill to reopen the federal government, were designed to kill the burgeoning national marketplace for hemp-derived THC and other cannabinoids.

The bill sets a new definition for industrial hemp that excludes “cannabinoids that are not capable of being naturally produced” by cannabis, and “cannabinoids that are capable of being naturally produced … but that were synthesized or manufactured outside the plant.”

The proposal also prohibits retailers from calling themselves “dispensaries,” noting that the term is reserved for licensed cannabis retailers.

Under the bill, retailers will still be allowed to sell products that contain less than 0.4 milligrams of THC.

Lawmakers approved the bill with bipartisan support in both chambers.

Meanwhile, Missouri Attorney General Catherine Hanaway last month sent cease and desist letters to 33 different retailers that were allegedly selling

Read More Here...